<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34932560</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7358</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>PLoS computational biology</Title><ISOAbbreviation>PLoS Comput Biol</ISOAbbreviation></Journal><ArticleTitle>Multiscale model for forecasting Sabin 2 vaccine virus household and community transmission.</ArticleTitle><Pagination><StartPage>e1009690</StartPage><MedlinePgn>e1009690</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1009690</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pcbi.1009690</ELocationID><Abstract><AbstractText>Since the global withdrawal of Sabin 2 oral poliovirus vaccine (OPV) from routine immunization, the Global Polio Eradication Initiative (GPEI) has reported multiple circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreaks. Here, we generated an agent-based, mechanistic model designed to assess OPV-related vaccine virus transmission risk in populations with heterogeneous immunity, demography, and social mixing patterns. To showcase the utility of our model, we present a simulation of mOPV2-related Sabin 2 transmission in rural Matlab, Bangladesh based on stool samples collected from infants and their household contacts during an mOPV2 clinical trial. Sabin 2 transmission following the mOPV2 clinical trial was replicated by specifying multiple, heterogeneous contact rates based on household and community membership. Once calibrated, the model generated Matlab-specific insights regarding poliovirus transmission following an accidental point importation or mass vaccination event. We also show that assuming homogeneous contact rates (mass action), as is common of poliovirus forecast models, does not accurately represent the clinical trial and risks overestimating forecasted poliovirus outbreak probability. Our study identifies household and community structure as an important source of transmission heterogeneity when assessing OPV-related transmission risk and provides a calibratable framework for expanding these analyses to other populations. Trial Registration: ClinicalTrials.gov This trial is registered with clinicaltrials.gov, NCT02477046.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Famulare</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Disease Modeling, Global Good, Intellectual Ventures, Bellevue, Washington, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Wesley</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0001-5664-7143</Identifier><AffiliationInfo><Affiliation>Institute for Disease Modeling, Global Good, Intellectual Ventures, Bellevue, Washington, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haque</LastName><ForeName>Rashidul</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-5100-136X</Identifier><AffiliationInfo><Affiliation>International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Platts-Mills</LastName><ForeName>James A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0002-4956-0418</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saha</LastName><ForeName>Parimalendu</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-2987-7493</Identifier><AffiliationInfo><Affiliation>International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aziz</LastName><ForeName>Asma B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Tahmina</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-7534-4033</Identifier><AffiliationInfo><Affiliation>International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Islam</LastName><ForeName>Md Ohedul</ForeName><Initials>MO</Initials><Identifier Source="ORCID">0000-0002-3403-6736</Identifier><AffiliationInfo><Affiliation>International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uddin</LastName><ForeName>Md Jashim</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-2466-7198</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bandyopadhyay</LastName><ForeName>Ananda S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0002-8395-2001</Identifier><AffiliationInfo><Affiliation>Bill &amp; Melinda Gates Foundation, Seattle, Washington, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yunus</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaman</LastName><ForeName>Khalequ</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taniuchi</LastName><ForeName>Mami</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7559-1998</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Engineering Systems and Environment, University of Virginia, Charlottesville, Virginia, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02477046</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Comput Biol</MedlineTA><NlmUniqueID>101238922</NlmUniqueID><ISSNLinking>1553-734X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001459" MajorTopicYN="N" Type="Geographic">Bangladesh</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032541" MajorTopicYN="N">Mass Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="Y">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="Y">Poliovirus Vaccine, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>I have read the journal’s policy and the authors of this manuscript have the following competing interests: AB is employed by the Bill and Melinda Gates Foundation. He was involved in the study design of the original clinical study. He was not involved in the modeling paper portion of the study. All other authors do not have any competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>21</Day><Hour>17</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34932560</ArticleId><ArticleId IdType="pmc">PMC8726461</ArticleId><ArticleId IdType="doi">10.1371/journal.pcbi.1009690</ArticleId><ArticleId IdType="pii">PCOMPBIOL-D-20-02227</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Khan F, Datta SD, Quddus A, Vertefeuille JF, Burns CC, Jorba J, et al.. Progress Toward Polio Eradication—Worldwide, January 2016–March 2018. MMWR Morb Mortal Wkly Rep 2019. 2018; 524–528. Available: doi: 10.15585/mmwr.mm6718a4</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6718a4</ArticleId><ArticleId IdType="pmc">PMC5944975</ArticleId><ArticleId IdType="pubmed">29746452</ArticleId></ArticleIdList></Reference><Reference><Citation>Poliomyelitis Prevention: Recommendations for Use of Inactivated Poliovirus Vaccine and Live Oral Poliovirus Vaccine. Pediatrics. 1997;99: 300 LP– 305. doi: 10.1542/peds.99.2.300</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.99.2.300</ArticleId><ArticleId IdType="pubmed">9024465</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization, Global Polio Eradication Initiative. Polio endgame strategy 2019–2023: eradication, integration, certification and containment. Geneva: World Health Organization; 2019. Available: https://apps.who.int/iris/handle/10665/329948</Citation></Reference><Reference><Citation>Duintjer Tebbens RJ, Pallansch MA, Kalkowska DA, Wassilak SGF, Cochi SL, Thompson KM. Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses. Risk analysis: an official publication of the Society for Risk Analysis. 2013;33: 703–749. doi: 10.1111/risa.12044</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/risa.12044</ArticleId><ArticleId IdType="pubmed">23521018</ArticleId></ArticleIdList></Reference><Reference><Citation>Famulare M, Chang S, Iber J, Zhao K, Adeniji JA, Bukbuk D, et al.. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria. Journal of virology. 2015;90: 317–331. doi: 10.1128/JVI.01532-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01532-15</ArticleId><ArticleId IdType="pmc">PMC4702576</ArticleId><ArticleId IdType="pubmed">26468545</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorba J, Diop OM, Iber J, Henderson E, Zhao K, Quddus A, et al.. Update on Vaccine-Derived Poliovirus Outbreaks—Worldwide, January 2018–June 2019. Morbidity and Mortality Weekly Report (MMWR). 2049; 1024–1028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6855511</ArticleId><ArticleId IdType="pubmed">31725706</ArticleId></ArticleIdList></Reference><Reference><Citation>Blake IM, Pons-Salort M, Molodecky NA, Diop OM, Chenoweth P, Bandyopadhyay AS, et al.. Type 2 Poliovirus Detection after Global Withdrawal of Trivalent Oral Vaccine. New England Journal of Medicine. 2018;379: 834–845. doi: 10.1056/NEJMoa1716677</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1716677</ArticleId><ArticleId IdType="pmc">PMC5985919</ArticleId><ArticleId IdType="pubmed">30157398</ArticleId></ArticleIdList></Reference><Reference><Citation>Macklin GR, O’Reilly KM, Grassly NC, Edmunds WJ, Mach O, Santhana Gopala Krishnan R, et al.. Evolving epidemiology of poliovirus serotype 2 following withdrawal of the type 2 oral poliovirus vaccine. Science. 2020; eaba1238. doi: 10.1126/science.aba1238</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aba1238</ArticleId><ArticleId IdType="pmc">PMC10805349</ArticleId><ArticleId IdType="pubmed">32193361</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson KM, Kalkowska DA. Review of poliovirus modeling performed from 2000 to 2019 to support global polio eradication. Expert Review of Vaccines. 2020; 1–25. doi: 10.1080/14760584.2020.1711058</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2020.1711058</ArticleId><ArticleId IdType="pmc">PMC7497282</ArticleId><ArticleId IdType="pubmed">32741232</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmandad H, Hu K, Tebbens RJD, Thompson KM. Development of an individual-based model for polioviruses: implications of the selection of network type and outcome metrics. Epidemiology and Infection. 2010/07/12. 2011;139: 836–848. doi: 10.1017/S0950268810001676</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268810001676</ArticleId><ArticleId IdType="pubmed">20619075</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson RN, Brooks-Pollock E. Detection, forecasting and control of infectious disease epidemics: modelling outbreaks in humans, animals and plants. Philosophical transactions of the Royal Society of London Series B, Biological sciences. 2019;374: 20190038. doi: 10.1098/rstb.2019.0038</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2019.0038</ArticleId><ArticleId IdType="pmc">PMC6553600</ArticleId><ArticleId IdType="pubmed">31056051</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartfield M, Alizon S. Introducing the outbreak threshold in epidemiology. PLoS pathogens. 2013/06/06. 2013;9: e1003277–e1003277. doi: 10.1371/journal.ppat.1003277</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003277</ArticleId><ArticleId IdType="pmc">PMC3680036</ArticleId><ArticleId IdType="pubmed">23785276</ArticleId></ArticleIdList></Reference><Reference><Citation>White LA, Forester JD, Craft ME. Disease outbreak thresholds emerge from interactions between movement behavior, landscape structure, and epidemiology. Proceedings of the National Academy of Sciences. 2018;115: 7374 LP– 7379. doi: 10.1073/pnas.1801383115</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1801383115</ArticleId><ArticleId IdType="pmc">PMC6048514</ArticleId><ArticleId IdType="pubmed">29941567</ArticleId></ArticleIdList></Reference><Reference><Citation>Alleman M, Jorba J, Greene S, Diop O, Iber J, Tallis G, et al.. Update on Vaccine-Derived Poliovirus Outbreaks—Worldwide July 2019-February 2020. MMWR Morb Mortal Wkly Re. 2020; 89–495. doi: 10.15585/mmwr.mm6916a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6916a1</ArticleId><ArticleId IdType="pmc">PMC7188410</ArticleId><ArticleId IdType="pubmed">32324719</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson KM, Duintjer Tebbens RJ. Modeling the dynamics of oral poliovirus vaccine cessation. The Journal of infectious diseases. 2014;210 Suppl: S475–84. doi: 10.1093/infdis/jit845</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jit845</ArticleId><ArticleId IdType="pubmed">25316870</ArticleId></ArticleIdList></Reference><Reference><Citation>Merler S, Ajelli M, Fumanelli L, Gomes MFC, Piontti AP y, Rossi L, et al.. Spatiotemporal spread of the 2014 outbreak of Ebola virus disease in Liberia and the effectiveness of non-pharmaceutical interventions: a computational modelling analysis. The Lancet Infectious Diseases. 2015;15: 204–211. doi: 10.1016/S1473-3099(14)71074-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(14)71074-6</ArticleId><ArticleId IdType="pmc">PMC4409131</ArticleId><ArticleId IdType="pubmed">25575618</ArticleId></ArticleIdList></Reference><Reference><Citation>Famulare M, Selinger C, McCarthy KA, Eckhoff PA, Chabot-Couture G. Assessing the stability of polio eradication after the withdrawal of oral polio vaccine. PLOS Biology. 2018;16: e2002468. Available: doi: 10.1371/journal.pbio.2002468</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.2002468</ArticleId><ArticleId IdType="pmc">PMC5942853</ArticleId><ArticleId IdType="pubmed">29702638</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong W, Gauld J, Famulare M. From Vaccine to Pathogen: Modeling Sabin 2 Vaccine Virus Reversion and Evolutionary Epidemiology. medRxiv. 2020; 2020.11.02. doi: 10.1101/2020.11.02.20224634 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.02.20224634</ArticleId><ArticleId IdType="pmc">PMC10491863</ArticleId><ArticleId IdType="pubmed">37692896</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniuchi M, Famulare M, Zaman K, Uddin MJ, Upfill-Brown AM, Ahmed T, et al.. Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study. The Lancet Infectious diseases. 2017;17: 1069–1079. doi: 10.1016/S1473-3099(17)30358-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(17)30358-4</ArticleId><ArticleId IdType="pmc">PMC5610141</ArticleId><ArticleId IdType="pubmed">28693854</ArticleId></ArticleIdList></Reference><Reference><Citation>Skinner GW. Family Systems and Demographic Processes. In: Kertzer DI, Fricke T, editors. Anthropological Demography: Toward a New Synthesis. University of Chicago Press; 1994.</Citation></Reference><Reference><Citation>Amin S. Family Structure and Change in Rural Bangladesh. Population Studies. 1998;52: 201–213.</Citation></Reference><Reference><Citation>Bangladesh Demographic and Health Survey 2004. Dhaka, Bangladesh, and Calverton, Maryland, USA;</Citation></Reference><Reference><Citation>Bangladesh Demographic and Health Survey 2014. Dhaka, Bangladesh, and Rockville, Maryland, USA;</Citation></Reference><Reference><Citation>WHO. Global Health Observatory data repository. [cited 6 May 2019]. Available: http://apps.who.int/gho/data/view.main.1520_62?lang=en</Citation></Reference><Reference><Citation>Brouwer AF, Eisenberg JNS, Pomeroy CD, Shulman LM, Hindiyeh M, Manor Y, et al.. Epidemiology of the silent polio outbreak in Rahat, Israel, based on modeling of environmental surveillance data. Proceedings of the National Academy of Sciences. 2018;115: E10625 LP–E10633. doi: 10.1073/pnas.1808798115</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1808798115</ArticleId><ArticleId IdType="pmc">PMC6233100</ArticleId><ArticleId IdType="pubmed">30337479</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaari R, Kaliner E, Grotto I, Katriel G, Moran-Gilad J, Sofer D, et al.. Modeling the spread of polio in an IPV-vaccinated population: lessons learned from the 2013 silent outbreak in southern Israel. BMC Medicine. 2016;14: 95. doi: 10.1186/s12916-016-0637-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-016-0637-z</ArticleId><ArticleId IdType="pmc">PMC4918056</ArticleId><ArticleId IdType="pubmed">27334457</ArticleId></ArticleIdList></Reference><Reference><Citation>Debes AK, Ali M, Azman AS, Yunus M, Sack DA. Cholera cases cluster in time and space in matlab, Bangladesh: Implications for targeted preventive interventions. International Journal of Epidemiology. 2016;45: 2134–2139. doi: 10.1093/ije/dyw267</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyw267</ArticleId><ArticleId IdType="pubmed">27789673</ArticleId></ArticleIdList></Reference><Reference><Citation>Giebultowicz S, Ali M, Yunus M, Emch M. A comparison of spatial and social clustering of cholera in Matlab, Bangladesh. Health and Place. 2011;17: 490–497. doi: 10.1016/j.healthplace.2010.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healthplace.2010.12.004</ArticleId><ArticleId IdType="pmc">PMC3056893</ArticleId><ArticleId IdType="pubmed">21195655</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Moreno D, Pascual M, Emch M, Yunus M. Spatial clustering in the spatio-temporal dynamics of endemic cholera. BMC Infectious Diseases. 2010;10: 1–12. doi: 10.1186/1471-2334-10-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-10-1</ArticleId><ArticleId IdType="pmc">PMC2846945</ArticleId><ArticleId IdType="pubmed">20205935</ArticleId></ArticleIdList></Reference><Reference><Citation>Joffret ML, Doté JW, Gumede N, Vignuzzi M, Bessaud M, Gouandjika-Vasilache I. Vaccine-derived polioviruses, Central African Republic, 2019. Emerging Infectious Diseases. 2021;27: 620–623. doi: 10.3201/eid2702.203173</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2702.203173</ArticleId><ArticleId IdType="pmc">PMC7853572</ArticleId><ArticleId IdType="pubmed">33496226</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulating vaccine-derived poliovirus type 2 –Global update. [cited 6 Jun 2021]. Available: https://www.who.int/emergencies/disease-outbreak-news/item/circulating-vaccine-derived-poliovirus-type-2-global-update</Citation></Reference><Reference><Citation>Van Damme P, De Coster I, Bandyopadhyay AS, Revets H, Withanage K, De Smedt P, et al.. The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study. The Lancet. 2019;394: 148–158. doi: 10.1016/S0140-6736(19)31279-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)31279-6</ArticleId><ArticleId IdType="pmc">PMC6626986</ArticleId><ArticleId IdType="pubmed">31174831</ArticleId></ArticleIdList></Reference><Reference><Citation>Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, et al.. Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases. PLOS Medicine. 2008;5: e74. doi: 10.1371/journal.pmed.0050074</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0050074</ArticleId><ArticleId IdType="pmc">PMC2270306</ArticleId><ArticleId IdType="pubmed">18366252</ArticleId></ArticleIdList></Reference><Reference><Citation>Emch M, Root ED, Giebultowicz S, Ali M, Perez-Heydrich C, Yunus M. Integration of Spatial and Social Network Analysis in Disease Transmission Studies. Annals of the Association of American Geographers Association of American Geographers. 2012;105: 1004–1015. doi: 10.1080/00045608.2012.671129</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00045608.2012.671129</ArticleId><ArticleId IdType="pmc">PMC3806718</ArticleId><ArticleId IdType="pubmed">24163443</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaman K, Ryun Kim D, Ali M, Ahmmed F, Im J, Islam MT, et al.. Can cholera ‘hotspots’ be converted to cholera ‘coldspots’ in cholera endemic countries? The Matlab, Bangladesh experience. International Journal of Infectious Diseases. 2020;95: 28–31. doi: 10.1016/j.ijid.2020.02.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.02.055</ArticleId><ArticleId IdType="pmc">PMC7294221</ArticleId><ArticleId IdType="pubmed">32126325</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Heydrich C, Furgurson JM, Giebultowicz S, Winston JJ, Yunus M, Streatfield PK, et al.. Social and spatial processes associated with childhood diarrheal disease in Matlab, Bangladesh. Health &amp; place. 2012/10/22. 2013;19: 45–52. doi: 10.1016/j.healthplace.2012.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healthplace.2012.10.002</ArticleId><ArticleId IdType="pmc">PMC3537872</ArticleId><ArticleId IdType="pubmed">23178328</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelfand HM, Leblanc DR, Fox JP, Conwell DP. Studies on the development of natural immunity to poliomyelitis in Louisiana. II. Description and analysis of episodes of infection observed in study group households. American Journal of Hygiene. 1957;65: 367–385. doi: 10.1093/oxfordjournals.aje.a119876</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a119876</ArticleId><ArticleId IdType="pubmed">13424522</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>